Eight patients (21%) had low serum C3 level and normal serum C4 level including 1 amyloidosis patient, 3 cryoglobulinemic GN patients, 2 proliferative GN with monoclonal IgM deposits patients, 1 LCDD patient, and 1 C3 GN patient. This evidence concerns the gene C4A and ganglioneuroma.